Friday, 6th of June 2008 |
CHILD SURVIVAL UPDATE 14/2008: TWO ON MEASLES
1) MEASLES ELIMINATION IN AUSTRALIA AND 17 EUROPEAN COUNTRIES
The present decade, starting with the 2001 creation of the Measles
Partnership, has not smiled on the measles virus; the next decade may mark
its passage from the medical books into the history books.
In this article from the Bulletin of the World Health Organization, also at
http://www.who.int/entity/bulletin/volumes/86/3/07-041129.pdf
Andrews and colleagues review progress to date of the continental efforts
to clear Australia and Europe of the measles virus. They focus on
serosurveillance as a tool for identifying areas at high risk of measles
reintroduction.
Age-specific measles seronegativity is a good marker for susceptibility to
measles. In well vaccinated populations, measles susceptibility, as
measured by seronegativity, should not exceed 5 percent in those aged 10 or
above.
In countries where routine application of a two dose schedule is the main
weapon against measles, serosurveillance of the kind described here is a
useful tool in identifying countries and areas most at risk of measles
outbreaks. Would it be useful anywhere else?
2) GENETIC DIVERSITY OF MEASLES VIRUS IN EUROPE
WHO's European region, committed to eliminating measles transmission by
2010, has used its network of reference laboratories to track the genetic
diversity of lab confirmed measles cases in the region.
In this article by Kremer and colleagues, which is also available to
Internet users at http://www.cdc.gov/eid/content/14/1/107.htm
the authors look at the genetic diversity of measles lab isolates from
Europe. Review of the lab data permits them to conclude that "importation
from other continents caused prolonged circulation and large outbreaks
after their introduction into unvaccinated and highly mobile populations."
Since intercontinental travel is unlikely to decline -- quite the contrary
-- only more vigorous vaccination efforts in all continents, both routine
and campaign, will reduce the flow of measles virus across national and
continental borders.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40956356 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |